Blueprint Medicines Corporation (BPMC) is traded on NASDAQ in USA. It is located in MASSACHUSETTS, U.S.A and employs 133 people. Blueprint Medicines is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap
' category with current market capitalization of 3.49 B. Blueprint Medicines Corporation conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 42.88 M outstanding shares of which 2.17 M shares are currently shorted by private and institutional investors with about 5.59 trading days to cover.
N/A currently holds about 390.65 M in cash with (103.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.97.
Check Blueprint Medicines Probability Of Bankruptcy